CD47 and neoplasm: DBE@CCNPs significantly inhibited tumor growth (Figure 9B–D), indicating triggering of effective antitumor immunity.[87] Additionally, some studies have shown that CD47 knockout tumor cells can be effectively phagocytized by primary macrophages, leading to tumor size reductions.[88]